Amnion-derived multipotent progenitor cells increase gain of incisional breaking strength and decrease incidence and...

Area of Science:

• Regenerative Medicine
• Wound Healing Research
• Cell-Based Therapies

Background:

• Acute wound failure, including laparotomy wound failure, is a significant surgical complication.
• Delayed wound-breaking strength recovery contributes to abdominal dehiscence and incisional hernias.
• Early fascial wounds exhibit delayed growth factor and cytokine expression.

Purpose of the Study:

• To accelerate and enhance laparotomy wound healing using amnion-derived multipotent cells (AMPs).
• To evaluate AMPs as a potential cell therapy for wound repair.
• To leverage AMPs' non-immunogenic and abundant properties.

Main Methods:

• AMPs were injected into rat abdominal walls before laparotomy.
• Cell viability and migration were assessed.
• Wound mechanical properties and incisional hernia incidence/severity were measured over 28 days.

Main Results:

• AMP cells remained viable in wounds for at least 28 days without migration.
• AMP therapy significantly increased laparotomy wound-breaking strength by postoperative day 7.
• Reduced incidence and size of incisional hernias were observed, with evidence of stimulated fibroplasia and angiogenesis.

Conclusions:

• AMP cell therapy effectively reduces laparotomy wound failure by accelerating wound healing.
• This approach leads to a decreased incidence of incisional hernias and smaller defect sizes.
• AMPs offer a promising therapeutic strategy for improving surgical wound repair.